Babich, John W.,Zimmerman, Craig,Joyal, John L.,Lu, Genliang
申请号：
AU2012294639
公开号：
AU2012294639B2
申请日:
2012.08.03
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Compounds according to Formula I and Formula II are potent inhibitors of PSMA activity: The invention also provides pharmaceutical compositions of a complex of a radionuclide and a Formula I compound or a Formula II compound and methods of using the radionuclide complex of a Formula I compound or a Formula II compound for treating or diagnosis of a disease or a condition associated with PSMA activity.
